Latest China News

Firebird Metals has achieved a significant technical milestone with its manganese iron phosphate precursor outperforming China industry benchmarks, setting the stage for commercial production at its Australian Demonstration Plant in 2026.

Jatcorp Limited has announced a fully underwritten pro-rata rights issue to raise approximately $4.2 million, aiming to strengthen working capital and accelerate growth in China and Southeast Asia. Eligible shareholders can subscribe at $0.15 per share with an option for additional shares under a Top-Up Facility.

PWR Holdings has appointed Sharyn Williams as its new CEO and Managing Director, marking a strategic leadership transition while the search for a new CFO is underway.

Merino & Co. has secured a significant new order from its Shanghai distribution partner, reinforcing its expanding footprint in China’s luxury apparel market and validating its strategic growth plans.

Sun Silver Limited has announced a substantial increase in its Maverick Springs Silver-Gold Project resource, adding 59 million ounces silver equivalent to reach 539 million ounces at a higher grade of 71g/t AgEq. This marks the third resource upgrade in under two years, underscoring the project's growing strategic importance amid shifting global silver supply dynamics.

VBX Limited has confirmed the quality and scale of its Wuudagu C bauxite deposit through comprehensive infill drilling, reinforcing its Preliminary Feasibility Study and advancing its Definitive Feasibility Study with metallurgical optimization.

Almonty Industries has announced a $15 million public offering of common shares in the US, aiming to accelerate development across its tungsten and molybdenum projects amid rising global demand.

Immutep has struck a strategic licensing deal with Dr. Reddy’s, granting rights to commercialise its novel cancer immunotherapy Eftilagimod Alfa across key emerging markets. The agreement includes a $20 million upfront payment and potential milestones exceeding $349 million.

Felix Gold Limited has successfully raised $18 million through a placement to fund exploration and advance near-term military-grade antimony production in Alaska. The capital injection positions the company to capitalize on strategic supply opportunities amid global market shifts.

Locksley Resources has raised A$17 million in an oversubscribed placement led by U.S. institutional investors, accelerating its strategy to develop a domestic supply chain for antimony and rare earths in California.

American Rare Earths has appointed mining veteran Mark Wall as CEO to lead its transition from exploration to production, focusing on advancing its flagship Halleck Creek project and expanding its U.S. market presence.

Telix Pharmaceuticals has dosed the first patient in the randomized expansion phase of its pivotal ProstACT Global Phase 3 trial for TLX591, targeting advanced prostate cancer. The trial is expanding globally, with regulatory submissions underway in the US and Europe.